BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  PAVmed Files 510(k) Submission With FDA for CarpX Device to Treat Carpal Tunnel Syndrome

  Designed to replace invasive surgery and shorten recovery time; addresses an estimated $1 billion market opportunity.

  November 28, 2017

   · 

  6 min read
• Drug Development

  ImmusanT Data Shows Up-Dosing Substantially Increases Nexvax2 Dose Levels That Are Safe and Tolerable, Further Supports Phase II Studies

  This study demonstrates that gradually increasing the dose from a low, well-tolerated starting dose enables Nexvax2 to be safe and tolerable without dose-limiting adverse events at a level of 900 μg,.

  November 28, 2017

   · 

  5 min read
• Business

  Applied Photophysics Expands Management Team and Strengthens Sales and Application Support

  The Company has also expanded its sales and scientific support teams across the US, UK and Germany with the addition of four Sales Managers and two more Application Scientists

  November 28, 2017

   · 

  3 min read
• Drug Development

  Takeda Initiates Phase I Clinical Trial of Zika Vaccine Candidate

  The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 subjects between the ages of 18 and 49 across the continental U.S. and U.S. territories.

  November 28, 2017

   · 

  8 min read
• Business

  Cosmos Holdings Announces Third Quarter 2017 Results

  Cosmos Holdings announced financial results for the quarter ended September 30, 2017.

  November 28, 2017

   · 

  2 min read
• Biotech Beach

  Cannabis Science Announces the Nearing Completion of a Novel Patentable Formulary Cannabinoid Medication to Treat Asthma/COPD Overlap Syndrome and Clinical Trials to Start Soon

  Our new formulary will target four aspects of this illness inflammation, airway constriction, capacity, and anxiety.

  November 28, 2017

   · 

  7 min read
• Drug Development

  PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL From EMA

  PhaseRx today announced that the EMA’s Committee for Orphan Medicinal Products has issued a positive opinion recommending orphan medicinal product designation for PRX-ASL, for the treatment of ASLD, PhaseRx’s second drug candidate to treat a urea cycle disorder.

  November 28, 2017

   · 

  5 min read
• BioMidwest

  Bio-Techne’s RNAscope Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-Ranging Research with over 1000 Publications

  Reaching 1,000 publications and increasing to an average of more than one publication per day, papers using RNAscope now feature regularly in top tier journals.

  November 28, 2017

   · 

  5 min read
• Drug Development

  NeuroproteXeon Announces Publication of Xenon Study to Lessen Cardiac Damage Following Out-of-Hospital Cardiac Arrest

  NeuroproteXeon announced the publication of a second finding from a randomized, controlled Phase II trial of inhaled xenon and oxygen, combined with hypothermia, for out-of-hospital cardiac arrest patients.

  November 28, 2017

   · 

  1 min read
• Business

  ARMO BioSciences Appoints Herb Cross as CFO

  Mr. Cross has over twenty years of experience, with executive leadership roles in both private and public biotechnology companies.

  November 28, 2017

   · 

  2 min read